Navigation Links
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Date:6/14/2013

://www.simcere.com/">http://www.simcere.com.

Bristol-Myers Squibb Forward Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, regarding the research, development and commercialization of pharmaceutical products. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that Orencia SC will become a commercially successful product in China. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2012, its Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Simcere Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions. These forward looking statements are based upon management
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
2. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
3. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
4. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
5. StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
6. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
9. Simcere Pharmaceutical Group to Announce Second Quarter 2012 Financial Results on Friday, August 10, 2012
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
11. Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  EP Global ... executives have recently contacted the Company about discussing ... as early as Monday, August 3, 2015.  Novartis ... as saying that the coming electronic contact lens ... dollars over the next several years.  Novartis partnered ...
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... second quarter ending June 30, 2015. ... We are excited to be near the completion of ... with topline results expected in the fourth quarter," stated ... Inc. "Translarna is now commercially available in 12 countries ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
(Date:7/31/2015)... Wilmington, DE (PRWEB) , ... July 31, 2015 ... ... long term care client base, with the recent implementation of Microsoft Dynamics GP ... provider in the industry, Intellitec is now supporting senior living communities in 16 ...
(Date:7/30/2015)... ... 31, 2015 , ... When responsible for the care of an aging loved ... through your mind: What happens if mom falls? Who will remind Dad to take ... plans. , But not taking time away from caregiving responsibilities can lead to bigger ...
(Date:7/30/2015)... ... July 31, 2015 , ... On July 22nd the Bradenton Herald ... plausible solutions for controlling the heroin outbreak. Ultimately the committee expressed lack of funding, ... perpetuating the heroin crisis in North Florida. The task force has proposed to instate ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that data standards for ... published for use on the CDISC website . These three Therapeutic Area ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating coach Simone Myers ... for women interested in improving their love lives using specific "lines" designed to ... to the public early this morning, has drawn praise from several dating and ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
... Westchester, Ill. A study in the Feb. 1 issue ... impairments in older men with obstructive sleep apnea (OSA) are ... , A modest link between OSA severity and ... longer statistically significant after controlling for total sleep time. ...
... Researchers at Stanford University School of Medicine have identified ... Blocking the expression of the protein slowed or prevented ... vulnerable to the conditions of low oxygen that occur ... inhibiting the protein inhibits the tumor,s ability to grow," ...
... radiotherapy delivery systems cut dose, side effects after rare ... The best way to treat a rare form of ... by targeted radiotherapy, U.S. researchers say. , Ependymoma affects ... but concerns about side effects have limited the use ...
... Reported; No Other Products Within the NutriSystem Food Portfolio ... NutriSystem Inc., a leading provider of weight management products ... its NutriSystem-branded Peanut Butter Granola Bar due to the ... include all peanut products manufactured from January 1, 2007 ...
... of small arteries at the surface of the brain redirects ... to tissue starved of nutrients and oxygen following a stroke, ... optimistic news," said David Kleinfeld, a physics professor at the ... in animal models of stroke. , Damage from stroke can ...
... Officials with Baylor Health Care System ... the Baylor Research Institute (BRI) as vice ... 1. (Photo: http://www.newscom.com/cgi-bin/prnh/20090130/DC65143 )Under his leadership, ... of its unique research technologies in areas ...
Cached Medicine News:Health News:Daytime impairments in older men with obstructive sleep apnea are related to total sleep time 2Health News:Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein 2Health News:Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein 3Health News:Aggressive Treatment Effective in Kids' Brain Cancer 2Health News:NutriSystem Expands Voluntary United States Recall of Peanut Butter Granola Breakfast Bar to Include Canada Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk 2Health News:NutriSystem Expands Voluntary United States Recall of Peanut Butter Granola Breakfast Bar to Include Canada Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk 3Health News:Mesh-like network of arteries adjusts to restore blood flow to stroke-injured brain 2Health News:Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer 2Health News:Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: